Pharmaids Pharmaceuticals Ltd.
BSE: 524572
₹28.01
₹0.05
(0.18%)
As on 10-Jun-2026IST
Market cap
₹99 Cr
Revenue (TTM)
₹28 Cr
P/E Ratio
--
P/B Ratio
2.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-12 Cr
-
ROE
-20.6 %
-
ROCE
-17.7 %
-
Industry P/E
44.6
-
EV/EBITDA
-9
-
Debt to Equity
0.2
-
Book Value
₹13.5
-
EPS
₹-3.8
-
Face value
10
-
Shares outstanding
35,267,812
10 Years Aggregate
CFO
₹-29.20 Cr
EBITDA
₹-36.28 Cr
Net Profit
₹-33.48 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pharmaids Pharma
| -41.2 | -11.1 | -17.6 | -51.6 | -2.3 | 4.7 | 27.8 |
|
BSE Healthcare
| 8.2 | 1.0 | 8.3 | 8.0 | 24.8 | 13.5 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Pharmaids Pharma
| -35.6 | 37.9 | 73.1 | 82.5 | -5.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pharmaids Pharma
|
28.0 | 98.8 | 27.9 | -11.6 | -56.0 | -26.9 | -- | 2.1 |
| 3,207.0 | 26,324.8 | 1,339.4 | 356.4 | 33.2 | 23.2 | 73.9 | 15.9 | |
| 430.5 | 16,488.6 | 2,268.6 | 150.1 | 10.6 | 5.4 | 92 | 4.2 | |
| 760.8 | 18,852.4 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.7 | 3.7 | |
| 854.6 | 15,313.9 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 10.8 | 1.7 | |
| 1,699.6 | 19,517.9 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.3 | |
| 164.1 | 21,907.3 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 1,188.1 | 19,619.4 | 1,284.3 | 134.4 | -- | 30.7 | 79.5 | 15.2 | |
| 454.7 | 18,354.8 | 3,738.7 | 316.7 | 12.5 | 7.5 | 58 | 3.8 | |
| 1,833.0 | 29,782.4 | 3,373.0 | 199.0 | 12.6 | 5.9 | 139.8 | 6.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Pharmaids Pharma
Wholesale of pharmaceutical and medical goods
-
Incorporated
1989
-
Chairman
--
-
Managing Director
--
-
Headquarters
Bengaluru, Karnataka
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Pharmaids Pharma
What is the current share price of Pharmaids Pharmaceuticals Ltd Today?
The share price of Pharmaids Pharmaceuticals Ltd is ₹28.01 (BSE) as of 10-Jun-2026 IST. Pharmaids Pharmaceuticals Ltd has given a return of -2.26% in the last 3 years.
What is the current PB & PE ratio of Pharmaids Pharmaceuticals Ltd?
Since, TTM earnings of Pharmaids Pharmaceuticals Ltd is negative, P/E ratio is not available.
The P/B ratio of Pharmaids Pharmaceuticals Ltd is 2.07 times as on 10-Jun-2026, a 45 discount to its peers’ median range of 3.73 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
4.08
|
|
2024
|
0.00
|
2.55
|
|
2023
|
0.00
|
2.13
|
|
2022
|
88.51
|
1.48
|
|
2021
|
122.99
|
1.35
|
What is the 52 Week High and Low of Pharmaids Pharmaceuticals Ltd?
The 52-week high and low of Pharmaids Pharmaceuticals Ltd are Rs 70.00 and Rs 25.60 as of 10-Jun-2026.
What is the market cap of Pharmaids Pharmaceuticals Ltd?
Pharmaids Pharmaceuticals Ltd has a market capitalisation of ₹ 99 Cr as on 10-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Pharmaids Pharmaceuticals Ltd?
Before investing in Pharmaids Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.